ye-public-hai-sab-jaanti-hai
Updated on: April 29, 2020 20:40 IST

Clinical trial started at PGIMER Chandigarh to position Sepsivac as drug for COVID-19 treatment: CSIR-IIIM Director

CSIR-IIIM Director and coordinator of trial programme for use of Sepsivac in COVID-19 treatment, Dr. Ram Vishwakarma said that Clinical trial has begun at PGIMER Chandigarh to position immunomodulator Sepsivac as a drug.

Latest Videos